全文获取类型
收费全文 | 5233篇 |
免费 | 256篇 |
国内免费 | 84篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 182篇 |
妇产科学 | 109篇 |
基础医学 | 594篇 |
口腔科学 | 126篇 |
临床医学 | 554篇 |
内科学 | 1011篇 |
皮肤病学 | 115篇 |
神经病学 | 428篇 |
特种医学 | 349篇 |
外科学 | 540篇 |
综合类 | 48篇 |
一般理论 | 4篇 |
预防医学 | 522篇 |
眼科学 | 139篇 |
药学 | 311篇 |
中国医学 | 4篇 |
肿瘤学 | 512篇 |
出版年
2024年 | 3篇 |
2023年 | 45篇 |
2022年 | 96篇 |
2021年 | 182篇 |
2020年 | 122篇 |
2019年 | 149篇 |
2018年 | 161篇 |
2017年 | 120篇 |
2016年 | 135篇 |
2015年 | 146篇 |
2014年 | 189篇 |
2013年 | 250篇 |
2012年 | 366篇 |
2011年 | 350篇 |
2010年 | 244篇 |
2009年 | 241篇 |
2008年 | 271篇 |
2007年 | 358篇 |
2006年 | 305篇 |
2005年 | 259篇 |
2004年 | 219篇 |
2003年 | 226篇 |
2002年 | 164篇 |
2001年 | 33篇 |
2000年 | 27篇 |
1999年 | 29篇 |
1998年 | 103篇 |
1997年 | 99篇 |
1996年 | 89篇 |
1995年 | 78篇 |
1994年 | 60篇 |
1993年 | 66篇 |
1992年 | 13篇 |
1991年 | 23篇 |
1990年 | 19篇 |
1989年 | 49篇 |
1988年 | 27篇 |
1987年 | 43篇 |
1986年 | 16篇 |
1985年 | 26篇 |
1984年 | 19篇 |
1983年 | 28篇 |
1982年 | 33篇 |
1981年 | 22篇 |
1980年 | 23篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 3篇 |
排序方式: 共有5573条查询结果,搜索用时 13 毫秒
81.
Roy Phitayakorn Dieter Morales-Garcia Jonathan Wanderer Carrie C. Lubitz Randall D. Gaz Antonia E. Stephen Jesse M. Ehrenfeld Gilbert H. Daniels Richard A. Hodin Sareh Parangi 《American journal of surgery》2013
Background
Optimal treatment of Graves’ disease (GD) remains controversial. The authors retrospectively reviewed the surgical cases of GD at a single academic tertiary center.Methods
Demographic, clinical, and surgical data were analyzed for all patients with GD undergoing thyroidectomy over 25 years, in 3 periods: 1985 to 1993 (n = 32), 1994 to 2002 (n = 91), and 2003 to 2010 (n = 177).Results
There were 300 patients with GD (85.7% women; mean age, 39.3 years; median length of follow-up, 24.6 months). Overall, perioperative morbidity occurred in 36 patients (12.0%), and there was no mortality. Thyroidectomy-specific morbidity was very low, and the incidental malignancy rate was 10.3%.Conclusions
Surgical treatment of GD has a very high safety profile, with low perioperative and thyroidectomy-specific morbidity, even in patients with overt hyperthyroidism. Incidental malignancy in patients with GD is not uncommon. 相似文献82.
83.
84.
85.
86.
87.
88.
Marc Martí-Pastor Angels Pont Mónica Ávila Olatz Garin Gemma Vilagut Carlos G. Forero Yolanda Pardo Ricard Tresserras Antonia Medina-Bustos Oriol Garcia-Codina Juan Cabasés Luis Rajmil Jordi Alonso Montse Ferrer 《Population health metrics》2018,16(1):14
Background
The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has improved its distribution, discriminatory power, and validity in the general population.Methods
A representative sample (N?=?7554) from the Catalan Health Interview Survey 2011–2012, aged ≥18, answered both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within groups of specific chronic conditions and their VAS mean.Results
A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ-5D-3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state within each specific chronic condition was very similar, regardless of the EQ-5D version (≤?30% in half of the 28 chronic conditions).Conclusion
Although the proportion of individuals with the best possible health state is still very high, our findings support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this new version to measure health in general population, as in the national health surveys.89.
Antonia Concetta Elia Gabriele Magara Claudio Caruso Loretta Masoero Marino Prearo Paola Arsieni 《Journal of toxicology and environmental health. Part A》2018,81(10):333-348
Arsenic (As) is a global contaminant of terrestrial and aquatic environments posing concern for environmental and human health. The effects of subacute concentrations of arsenic trioxide (AsIII) and dimethylarsinic acid (DMAV) were examined using Crandell Rees feline kidney (CRFK), human hepatocellular carcinoma (PLC/PRF/5), and epithelioma papulosum cyprini (EPC). Whole monolayer with suffering cells (confluence 100%, pyknosis and refractive cells; value scale = 2) led to identification of subacute As concentrations for the three cell lines. The selected AsIII concentrations were 1.33 µM for CRFK and 33.37 µM for PLC/PRF/5 and EPC, at 48 hr time point. The selected DMAV concentrations were 0.67 mM for PLC/PRF/5, 1.33 mM for CRFK, and 2.67 mM for EPC for 48 hr. Unlike the AsIII test, the three cell lines did not exhibit marked susceptibility to DMAV-mediated toxicity. Several oxidative stress biomarker levels, directly or indirectly associated with reactive oxygen species (ROS) elimination including superoxide dismutase, catalase, glutathione peroxidases, glutathione reductase, glutathione S-transferase, glyoxalase I, glyoxalase II, and total glutathione, were determined in the three cell lines at 24 and 48 hr. Antioxidant responses in metal-treated cells were significantly altered compared to controls, suggesting a perturbation of redox state. The weakening of antioxidant pathway in either healthy or tumoral cells was greater using AsIII than DMAV. Differences in level of several oxidative stress biomarkers suggest that the oxidative stress mechanism induced by AsIII is distinctly different from DMAV. Multifaceted mechanisms of action underlying ROS generation in tumor and nontumor cells versus AsIII and DMAV exposure are thus involved. Since As-mediated toxicity is quite complex, more data regarding both oxidant-enhancement and oxidant-lowering strategies may be useful to improve knowledge regarding the influence of As on human and animal cells. 相似文献
90.